Literature DB >> 15133597

Quality of life in patients with schizophrenia--comparison of self-report and proxy assessments.

Angela Becchi1, Paola Rucci, Anna Placentino, Giovanni Neri, Giovanni de Girolamo.   

Abstract

BACKGROUND: While Quality Of Life (QOL) in subjects suffering from schizophrenia has been studied using a variety of generic or specific instruments, only very few studies have analyzed the agreement between patients and proxy ratings on patients' QOL.
METHODS: We administered the World Health Organization Quality of Life assessment instrument (WHOQOL-100) to 292 patients and the Quality of Life for Proxies (QOL-P) to their proxies, respectively; the QOL-P is a 30-item instrument derived from the WHOQOL-100 and adapted for administration to a key informant.
RESULTS: Agreement between patients and proxies on the four main QOL areas was highest for the physical area (intraclass correlation coefficient, ICC = 0.41) and lowest for the psychological area (ICC = 0.29). In line with the results of other studies comparing patients' and proxies' ratings, proxies generally underestimated patients' physical and psychological QOL. Moreover, the agreement between patients' and proxies' ratings was consistently higher across all QOL areas when the proxy was a relative compared to a non-relative proxy.
CONCLUSIONS: The agreement between patients and proxies in QOL assessment is modest, but it is relatively higher when observable aspects of QOL are rated and when the proxy who makes the evaluation is a family member who has closer contacts with the patient. In order to obtain a comprehensive picture of patients' QOL, it would be advisable to compare patients' ratings with the assessments made by close informants.

Entities:  

Mesh:

Year:  2004        PMID: 15133597     DOI: 10.1007/s00127-004-0761-5

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  21 in total

Review 1.  Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.

Authors:  A George Awad
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

2.  Subjective and objective quality of life in schizophrenia.

Authors:  Jenille M Narvaez; Elizabeth W Twamley; Christine L McKibbin; Robert K Heaton; Thomas L Patterson
Journal:  Schizophr Res       Date:  2007-10-04       Impact factor: 4.939

3.  How do proxy responses and proxy-assisted responses differ from what Medicare beneficiaries might have reported about their health care?

Authors:  Marc N Elliott; Megan K Beckett; Kelly Chong; Katrin Hambarsoomians; Ron D Hays
Journal:  Health Serv Res       Date:  2008-06       Impact factor: 3.402

4.  What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder.

Authors:  Martin Aigner; Sophie Förster-Streffleur; Wolfgang Prause; Marion Freidl; Maria Weiss; Michael Bach
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-01       Impact factor: 4.328

5.  Childhood temperament is associated with distress, anxiety and reduced quality of life in schizophrenia spectrum disorders.

Authors:  Brandee Feola; Kristan Armstrong; Neil D Woodward; Stephan Heckers; Jennifer Urbano Blackford
Journal:  Psychiatry Res       Date:  2019-03-11       Impact factor: 3.222

6.  Evidence for inhibited temperament as a transdiagnostic factor across mood and psychotic disorders.

Authors:  Brandee Feola; Kristan Armstrong; Elizabeth A Flook; Neil D Woodward; Stephan Heckers; Jennifer Urbano Blackford
Journal:  J Affect Disord       Date:  2020-05-23       Impact factor: 4.839

Review 7.  Proxies and other external raters: methodological considerations.

Authors:  A Lynn Snow; Karon F Cook; Pay-Shin Lin; Robert O Morgan; Jay Magaziner
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

Review 8.  Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment.

Authors:  Louis S Matza; Robert Buchanan; Scot Purdon; Jessica Brewster-Jordan; Yang Zhao; Dennis A Revicki
Journal:  Schizophr Bull       Date:  2006-07-07       Impact factor: 9.306

9.  Validation of the modified DUKE-UNC Functional Social Support Questionnaire in patients with schizophrenia.

Authors:  Laia Mas-Expósito; Juan Antonio Amador-Campos; Juana Gómez-Benito; Lluís Lalucat-Jo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-12-11       Impact factor: 4.328

10.  Quality of life in mentally ill, physically ill and healthy individuals: the validation of the Greek version of the World Health Organization Quality of Life (WHOQOL-100) questionnaire.

Authors:  Maria Ginieri-Coccossis; Eugenia Triantafillou; Vlasis Tomaras; Ioannis A Liappas; George N Christodoulou; George N Papadimitriou
Journal:  Ann Gen Psychiatry       Date:  2009-10-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.